Dr. Md. Ashikuzzaman – Top Hematologist & BMT Specialist, Khulna
Dr. Md. Ashikuzzaman is a Consultant in the Hematology & Bone Marrow Transplant Department at Khulna Medical College & Hospital, with over 13 years of distinguished clinical, academic, and systemic hematology experience. As an eminent Hematologist and Blood Cancer Specialist, he provides expert care for severe and complex blood disorders, uniquely focusing on highly fatal and rare conditions such as PNH, TTP, aplastic anemia, HLH, and MDS. Patients seeking expert hematological evaluation receive evidence-based treatments tailored to halt bone marrow failure, manage acute bleeding or clotting crises, and achieve long-term remission through cellular therapies. His medical practice combines high-precision flow cytometry diagnostics with individualized, life-saving patient care plans.
Professional Biography
Dr. Md. Ashikuzzaman completed his MBBS degree, establishing a comprehensive clinical foundation in general medical sciences. Demonstrating a profound commitment to advanced blood cancer care, he entered the prestigious BCS (Health) cadre and pursued highly rigorous postgraduate specialization, earning his Doctor of Medicine (MD) in Hematology. To achieve unparalleled diagnostic precision, he pursued Advanced Training in Flowcytometry in India, enabling him to accurately detect microscopic blood cancers and rare cellular defects (like PNH). Furthermore, he received specialized training in Bone Marrow Transplantation, bringing world-class curative therapies to his patients. Finding the best Hematologist in Khulna leads patients to rely on his 13+ years of dedicated clinical expertise at Khulna Medical College & Hospital, the apex government medical institution of Bangladesh.
His primary clinical focus includes life-saving immunosuppressive therapy (IST) for aplastic anemia, emergency therapeutic plasma exchange (TPE) coordination for TTP, targeted biological therapies for PNH, intensive immunochemotherapy for HLH, and comprehensive bone marrow evaluation for myelodysplastic syndromes (MDS). His diagnostic framework incorporates advanced flow cytometry interpretation, bone marrow aspiration and trephine biopsy analysis, cytogenetic profiling, and comprehensive hematological risk stratification to formulate effective, long-term survival strategies.
At-a-Glance Profile Card
| Profile Field | Details |
| Full Name | Dr. Md. Ashikuzzaman |
| Primary Specialty | Hematology (Blood Cancer & Blood Diseases) |
| Secondary Specialties | Bone Marrow Transplant & Advanced Flow Cytometry |
| Designation | Consultant, Hematology & Bone Marrow Transplant Dept |
| Workplace | Khulna Medical College & Hospital, Khulna |
| Total Experience | 13+ Years |
| Location | Khulna, Bangladesh |
Qualifications & Education
MBBS – Bachelor of Medicine and Bachelor of Surgery
BCS (Health) – Bangladesh Civil Service (Health Cadre)
MD (Hematology) – Doctor of Medicine in Hematology
Advanced Training – Flowcytometry (India)
Specialized Training – Bone Marrow Transplantation (BMT)
Designation & Workplace
Designation: Consultant, Hematology & Bone Marrow Transplant Dept
Workplace: Khulna Medical College & Hospital, Khulna
Diseases Treated
Paroxysmal nocturnal hemoglobinuria (PNH) requires targeted complement inhibitors and bone marrow monitoring.
Thrombotic thrombocytopenic purpura (TTP) demands absolute emergency therapeutic plasma exchange (plasmapheresis).
Aplastic anemia needs aggressive immunosuppressive therapy (ATG/Cyclosporine) or bone marrow transplant.
Hemophagocytic lymphohistiocytosis (HLH) requires extremely urgent immunochemotherapy to suppress a hyperactive immune system.
Myelodysplastic syndromes (MDS) demand specialized targeted therapies and frequent blood transfusions to prevent progression to leukemia.
Acute Leukemias (AML/ALL) require intensive induction chemotherapy and flow cytometry monitoring.
Chronic Leukemias (CML/CLL) demand targeted tyrosine kinase inhibitors or biological agents.
Lymphomas (Hodgkin & Non-Hodgkin) require systemic immunochemotherapy regimens.
Multiple Myeloma requires targeted proteasome inhibitors and autologous stem cell transplant evaluation.
Thalassemia demands chronic blood transfusion regimens and strict iron chelation therapy.
Hemophilia requires factor replacement therapy and acute bleeding management.
Immune Thrombocytopenia (ITP) demands corticosteroids, targeted biologics, or splenectomy evaluation.
Deep Vein Thrombosis (DVT) & Pulmonary Embolism requires advanced anticoagulation and thrombophilia screening.
Clinical Specialties & Treatment Areas
Bone Marrow Failure & Rare Blood Syndromes: Precision management for conditions where the bone marrow stops producing blood (Aplastic Anemia, MDS) or where blood cells are abnormally destroyed (PNH).
Hematologic Emergencies (TTP & HLH): Rapid-response, life-saving interventions for devastating conditions that rapidly destroy platelets and red blood cells, causing multi-organ failure.
Advanced Hematopathology (Flow Cytometry): Expert interpretation of cellular markers to instantly and accurately diagnose complex leukemias and rare red blood cell defects.
Advanced Procedure Breakdown
Flow Cytometry Interpretation
Flow cytometry is a highly advanced laser-based technology used to analyze the physical and chemical characteristics of cells. Using his specialized training from India, Dr. Ashikuzzaman interprets these complex reports to definitively diagnose PNH (by detecting the absence of specific protective proteins like CD55 and CD59 on red blood cells) and to perfectly classify the exact subtype of leukemia, ensuring the correct chemotherapy is chosen.
Bone Marrow Aspiration & Trephine Biopsy
The gold standard procedure for diagnosing blood cancers and marrow failures. Under local anesthesia, Dr. Ashikuzzaman extracts liquid marrow and a solid bone core from the hip bone. He meticulously analyzes the cellular structure to differentiate between conditions like Aplastic Anemia (an empty marrow) and MDS (a crowded but dysfunctional marrow).
Coordination of Therapeutic Plasma Exchange (TPE)
For patients with TTP, the blood is filled with microscopic blood clots because a specific enzyme (ADAMTS13) is missing. This is a fatal emergency. Dr. Ashikuzzaman immediately coordinates therapeutic plasma exchange (plasmapheresis), a procedure that filters the patient's blood through a machine to remove the clot-causing antibodies and replace the missing enzyme with fresh donor plasma.
Condition-Specific Deep Dives
Paroxysmal Nocturnal Hemoglobinuria (PNH)
An ultra-rare, acquired genetic blood disease. A mutation in the bone marrow stem cells causes them to produce red blood cells that lack a protective protein shield. As a result, the body's own immune system (the complement system) mistakenly destroys these red blood cells (hemolysis). Patients experience severe fatigue, dark (cola-colored) urine in the morning, and a very high risk of fatal blood clots in unusual veins.
Thrombotic Thrombocytopenic Purpura (TTP)
A terrifying, life-threatening blood disorder where microscopic blood clots form in the small blood vessels throughout the entire body. These clots consume the body's platelets (causing a dangerously low platelet count) and shred red blood cells as they squeeze past the clots. Patients present with fever, confusion (clots in the brain), kidney failure, and pinpoint red spots on the skin (petechiae). It requires immediate plasmapheresis.
Hemophagocytic Lymphohistiocytosis (HLH)
An extreme, rapidly fatal hyperinflammatory syndrome. The immune system becomes wildly overactive and starts producing too many activated immune cells (macrophages and T-cells). Instead of fighting infection, these cells literally start "eating" (phagocytosing) the patient's own healthy red blood cells, white blood cells, and platelets. It presents with unremitting high fever, a massively enlarged spleen, and rapid liver failure, requiring urgent, heavy immune-suppressing chemotherapy.
The Doctor’s Clinical Approach
Dr. Md. Ashikuzzaman utilizes over 13 years of profound clinical wisdom to approach highly volatile, acute hematological emergencies. His philosophy emphasizes extremely fast diagnostic triage using advanced flow cytometry, aggressive and immediate initiation of systemic treatments for fast-progressing bone marrow failures, and providing deep, compassionate counseling for patients navigating the terrifying prospect of bone marrow transplantation.
Specialized Risk Factors
Emergency Callout: Immediate emergency medical evaluation is required if a patient experiences sudden confusion, fever, and hundreds of tiny red/purple dots (petechiae) on their skin (classic signs of TTP), a patient with aplastic anemia or leukemia develops a fever over 100.4°F (38°C) with chills (Febrile Neutropenia), or a patient experiences sudden, severe, and unrelenting bone pain or unexplained massive bruising.
Certifications & Professional Memberships
Member, Bangladesh Medical and Dental Council (BMDC)
Consultant, BCS (Health) Cadre
Member, Hematology Society of Bangladesh
Patient Visit Preparation Checklist
Bring all prior Complete Blood Count (CBC) reports, peripheral blood smear reviews, bone marrow biopsy slides/reports, and flow cytometry results.
Crucial for Anemias: Bring records of any recent blood or platelet transfusions, including dates and exact volumes received.
Maintain a complete list of current prescription medications, particularly any iron supplements, blood thinners, or immunosuppressants.
Keep a detailed symptom diary noting extreme fatigue, night sweats, unexplained fevers, or the appearance of new bruises or dark urine.
Last Modified: October 28, 2026